0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Plasma Fractionation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-4176
Home | Market Reports | Health| Pharmacy
Global Plasma Fractionation Market Insights and Forecast to 2028
BUY CHAPTERS

Plasma Fractionation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-4176
Report
August 2025
Pages:138
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Plasma Fractionation- Market Size

The global market for Plasma Fractionation was estimated to be worth US$ 35330 million in 2024 and is forecast to a readjusted size of US$ 58200 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.

Plasma Fractionation- Market

Plasma Fractionation- Market

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation. In this report, we mainly study the Blood Plasma Fractionation products, such as: Immune Globulin, Coagulation Factor, Albumin, etc.
Market Drivers:
Increasing Demand for Plasma-Derived Therapies: The rising prevalence of chronic diseases, such as immune deficiencies, hemophilia, and autoimmune disorders, has led to increased demand for plasma-derived products like immunoglobulins, clotting factors, and albumin, driving the blood plasma fractionation market.
Aging Population: The global aging population is more prone to chronic diseases and conditions requiring plasma-derived therapies, contributing to the growth of the plasma fractionation market.
Growing Use of Immunoglobulins: Immunoglobulins are increasingly used in the treatment of a wide range of diseases, including primary and secondary immune deficiencies, boosting the need for blood plasma fractionation to produce these therapies.
Rising Healthcare Expenditure and Improved Healthcare Access: Expanding healthcare infrastructure in developing countries, combined with rising healthcare expenditure, is driving demand for advanced medical treatments and plasma-derived products.
Market Challenges:
High Costs of Plasma-Derived Products: The complex and time-consuming process of plasma fractionation leads to high costs for plasma-derived products, making these treatments less accessible, particularly in low-income regions.
Limited Plasma Supply: The availability of plasma for fractionation is often limited by low donation rates, regulatory restrictions, and the lengthy process of screening and collecting plasma, leading to supply shortages.
Stringent Regulatory Framework: Plasma fractionation is subject to rigorous regulatory requirements to ensure safety and efficacy. Meeting these regulations can increase development costs and slow the introduction of new products to the market.
Complex Manufacturing Process: The plasma fractionation process is technically challenging and requires significant investment in infrastructure, equipment, and skilled labor, posing barriers for new entrants and smaller manufacturers.
The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.
The classification of Blood Plasma Fractionation includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Blood Plasma Fractionation market.
North America is the largest consumption place, with a revenue market share nearly 40 % in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Blood Plasma Fractionation.
This report aims to provide a comprehensive presentation of the global market for Plasma Fractionation, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Plasma Fractionation by region & country, by Type, and by Application.
The Plasma Fractionation market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Fractionation.
Market Segmentation

Scope of Plasma Fractionation- Market Report

Report Metric Details
Report Name Plasma Fractionation- Market
Forecasted market size in 2031 US$ 58200 million
CAGR 7.5%
Forecasted years 2025 - 2031
Segment by Type
  • Albumin
  • Immune Globulin
  • Coagulation Factor
  • Others
Segment by Application
  • Hospital
  • Retail Pharmacy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Plasma Fractionation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Plasma Fractionation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Plasma Fractionation in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Plasma Fractionation- Market size in 2031?

Ans: The Plasma Fractionation- Market size in 2031 will be US$ 58200 million.

What is the Plasma Fractionation- Market share by type?

Ans: In 2023, Immune Globulin accounted for a share of 51% in the global Blood Plasma Fractionation market.

What is the Plasma Fractionation- Market share by region?

Ans: North America is the largest consumption place, with a revenue market share nearly 40 % in 2023.

Who are the main players in the Plasma Fractionation- Market report?

Ans: The main players in the Plasma Fractionation- Market are Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics

What are the Application segmentation covered in the Plasma Fractionation- Market report?

Ans: The Applications covered in the Plasma Fractionation- Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Plasma Fractionation- Market report?

Ans: The Types covered in the Plasma Fractionation- Market report are Albumin, Immune Globulin, Coagulation Factor, Others

1 Market Overview
1.1 Plasma Fractionation Product Introduction
1.2 Global Plasma Fractionation Market Size Forecast (2020-2031)
1.3 Plasma Fractionation Market Trends & Drivers
1.3.1 Plasma Fractionation Industry Trends
1.3.2 Plasma Fractionation Market Drivers & Opportunity
1.3.3 Plasma Fractionation Market Challenges
1.3.4 Plasma Fractionation Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Plasma Fractionation Players Revenue Ranking (2024)
2.2 Global Plasma Fractionation Revenue by Company (2020-2025)
2.3 Key Companies Plasma Fractionation Manufacturing Base Distribution and Headquarters
2.4 Key Companies Plasma Fractionation Product Offered
2.5 Key Companies Time to Begin Mass Production of Plasma Fractionation
2.6 Plasma Fractionation Market Competitive Analysis
2.6.1 Plasma Fractionation Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Plasma Fractionation Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Fractionation as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Albumin
3.1.2 Immune Globulin
3.1.3 Coagulation Factor
3.1.4 Others
3.2 Global Plasma Fractionation Sales Value by Type
3.2.1 Global Plasma Fractionation Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Plasma Fractionation Sales Value, by Type (2020-2031)
3.2.3 Global Plasma Fractionation Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Retail Pharmacy
4.1.3 Other
4.2 Global Plasma Fractionation Sales Value by Application
4.2.1 Global Plasma Fractionation Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Plasma Fractionation Sales Value, by Application (2020-2031)
4.2.3 Global Plasma Fractionation Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Plasma Fractionation Sales Value by Region
5.1.1 Global Plasma Fractionation Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Plasma Fractionation Sales Value by Region (2020-2025)
5.1.3 Global Plasma Fractionation Sales Value by Region (2026-2031)
5.1.4 Global Plasma Fractionation Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Plasma Fractionation Sales Value, 2020-2031
5.2.2 North America Plasma Fractionation Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Plasma Fractionation Sales Value, 2020-2031
5.3.2 Europe Plasma Fractionation Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Plasma Fractionation Sales Value, 2020-2031
5.4.2 Asia Pacific Plasma Fractionation Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Plasma Fractionation Sales Value, 2020-2031
5.5.2 South America Plasma Fractionation Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Plasma Fractionation Sales Value, 2020-2031
5.6.2 Middle East & Africa Plasma Fractionation Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Plasma Fractionation Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Plasma Fractionation Sales Value, 2020-2031
6.3 United States
6.3.1 United States Plasma Fractionation Sales Value, 2020-2031
6.3.2 United States Plasma Fractionation Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Plasma Fractionation Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Plasma Fractionation Sales Value, 2020-2031
6.4.2 Europe Plasma Fractionation Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Plasma Fractionation Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Plasma Fractionation Sales Value, 2020-2031
6.5.2 China Plasma Fractionation Sales Value by Type (%), 2024 VS 2031
6.5.3 China Plasma Fractionation Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Plasma Fractionation Sales Value, 2020-2031
6.6.2 Japan Plasma Fractionation Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Plasma Fractionation Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Plasma Fractionation Sales Value, 2020-2031
6.7.2 South Korea Plasma Fractionation Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Plasma Fractionation Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Plasma Fractionation Sales Value, 2020-2031
6.8.2 Southeast Asia Plasma Fractionation Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Plasma Fractionation Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Plasma Fractionation Sales Value, 2020-2031
6.9.2 India Plasma Fractionation Sales Value by Type (%), 2024 VS 2031
6.9.3 India Plasma Fractionation Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Takeda
7.1.1 Takeda Profile
7.1.2 Takeda Main Business
7.1.3 Takeda Plasma Fractionation Products, Services and Solutions
7.1.4 Takeda Plasma Fractionation Revenue (US$ Million) & (2020-2025)
7.1.5 Takeda Recent Developments
7.2 CSL
7.2.1 CSL Profile
7.2.2 CSL Main Business
7.2.3 CSL Plasma Fractionation Products, Services and Solutions
7.2.4 CSL Plasma Fractionation Revenue (US$ Million) & (2020-2025)
7.2.5 CSL Recent Developments
7.3 Grifols
7.3.1 Grifols Profile
7.3.2 Grifols Main Business
7.3.3 Grifols Plasma Fractionation Products, Services and Solutions
7.3.4 Grifols Plasma Fractionation Revenue (US$ Million) & (2020-2025)
7.3.5 Grifols Recent Developments
7.4 Octapharma
7.4.1 Octapharma Profile
7.4.2 Octapharma Main Business
7.4.3 Octapharma Plasma Fractionation Products, Services and Solutions
7.4.4 Octapharma Plasma Fractionation Revenue (US$ Million) & (2020-2025)
7.4.5 Octapharma Recent Developments
7.5 Kedrion
7.5.1 Kedrion Profile
7.5.2 Kedrion Main Business
7.5.3 Kedrion Plasma Fractionation Products, Services and Solutions
7.5.4 Kedrion Plasma Fractionation Revenue (US$ Million) & (2020-2025)
7.5.5 Kedrion Recent Developments
7.6 LFB Group
7.6.1 LFB Group Profile
7.6.2 LFB Group Main Business
7.6.3 LFB Group Plasma Fractionation Products, Services and Solutions
7.6.4 LFB Group Plasma Fractionation Revenue (US$ Million) & (2020-2025)
7.6.5 LFB Group Recent Developments
7.7 Biotest
7.7.1 Biotest Profile
7.7.2 Biotest Main Business
7.7.3 Biotest Plasma Fractionation Products, Services and Solutions
7.7.4 Biotest Plasma Fractionation Revenue (US$ Million) & (2020-2025)
7.7.5 Biotest Recent Developments
7.8 BPL
7.8.1 BPL Profile
7.8.2 BPL Main Business
7.8.3 BPL Plasma Fractionation Products, Services and Solutions
7.8.4 BPL Plasma Fractionation Revenue (US$ Million) & (2020-2025)
7.8.5 BPL Recent Developments
7.9 RAAS
7.9.1 RAAS Profile
7.9.2 RAAS Main Business
7.9.3 RAAS Plasma Fractionation Products, Services and Solutions
7.9.4 RAAS Plasma Fractionation Revenue (US$ Million) & (2020-2025)
7.9.5 RAAS Recent Developments
7.10 CBPO
7.10.1 CBPO Profile
7.10.2 CBPO Main Business
7.10.3 CBPO Plasma Fractionation Products, Services and Solutions
7.10.4 CBPO Plasma Fractionation Revenue (US$ Million) & (2020-2025)
7.10.5 CBPO Recent Developments
7.11 Hualan Bio
7.11.1 Hualan Bio Profile
7.11.2 Hualan Bio Main Business
7.11.3 Hualan Bio Plasma Fractionation Products, Services and Solutions
7.11.4 Hualan Bio Plasma Fractionation Revenue (US$ Million) & (2020-2025)
7.11.5 Hualan Bio Recent Developments
7.12 Tiantan Bio
7.12.1 Tiantan Bio Profile
7.12.2 Tiantan Bio Main Business
7.12.3 Tiantan Bio Plasma Fractionation Products, Services and Solutions
7.12.4 Tiantan Bio Plasma Fractionation Revenue (US$ Million) & (2020-2025)
7.12.5 Tiantan Bio Recent Developments
7.13 Shuanglin Bio
7.13.1 Shuanglin Bio Profile
7.13.2 Shuanglin Bio Main Business
7.13.3 Shuanglin Bio Plasma Fractionation Products, Services and Solutions
7.13.4 Shuanglin Bio Plasma Fractionation Revenue (US$ Million) & (2020-2025)
7.13.5 Shuanglin Bio Recent Developments
7.14 Boya Bio
7.14.1 Boya Bio Profile
7.14.2 Boya Bio Main Business
7.14.3 Boya Bio Plasma Fractionation Products, Services and Solutions
7.14.4 Boya Bio Plasma Fractionation Revenue (US$ Million) & (2020-2025)
7.14.5 Boya Bio Recent Developments
7.15 Yuanda Shuyang
7.15.1 Yuanda Shuyang Profile
7.15.2 Yuanda Shuyang Main Business
7.15.3 Yuanda Shuyang Plasma Fractionation Products, Services and Solutions
7.15.4 Yuanda Shuyang Plasma Fractionation Revenue (US$ Million) & (2020-2025)
7.15.5 Yuanda Shuyang Recent Developments
7.16 Weiguang Bio
7.16.1 Weiguang Bio Profile
7.16.2 Weiguang Bio Main Business
7.16.3 Weiguang Bio Plasma Fractionation Products, Services and Solutions
7.16.4 Weiguang Bio Plasma Fractionation Revenue (US$ Million) & (2020-2025)
7.16.5 Weiguang Bio Recent Developments
7.17 Nanyue Bio
7.17.1 Nanyue Bio Profile
7.17.2 Nanyue Bio Main Business
7.17.3 Nanyue Bio Plasma Fractionation Products, Services and Solutions
7.17.4 Nanyue Bio Plasma Fractionation Revenue (US$ Million) & (2020-2025)
7.17.5 Nanyue Bio Recent Developments
7.18 KM Biologics
7.18.1 KM Biologics Profile
7.18.2 KM Biologics Main Business
7.18.3 KM Biologics Plasma Fractionation Products, Services and Solutions
7.18.4 KM Biologics Plasma Fractionation Revenue (US$ Million) & (2020-2025)
7.18.5 KM Biologics Recent Developments
8 Industry Chain Analysis
8.1 Plasma Fractionation Industrial Chain
8.2 Plasma Fractionation Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Plasma Fractionation Sales Model
8.5.2 Sales Channel
8.5.3 Plasma Fractionation Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
 Table 1. Plasma Fractionation Market Trends
 Table 2. Plasma Fractionation Market Drivers & Opportunity
 Table 3. Plasma Fractionation Market Challenges
 Table 4. Plasma Fractionation Market Restraints
 Table 5. Global Plasma Fractionation Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Plasma Fractionation Revenue Market Share by Company (2020-2025)
 Table 7. Key Companies Plasma Fractionation Manufacturing Base Distribution and Headquarters
 Table 8. Key Companies Plasma Fractionation Product Type
 Table 9. Key Companies Time to Begin Mass Production of Plasma Fractionation
 Table 10. Global Plasma Fractionation Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Fractionation as of 2024)
 Table 12. Mergers & Acquisitions, Expansion Plans
 Table 13. Global Plasma Fractionation Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 14. Global Plasma Fractionation Sales Value by Type (2020-2025) & (US$ Million)
 Table 15. Global Plasma Fractionation Sales Value by Type (2026-2031) & (US$ Million)
 Table 16. Global Plasma Fractionation Sales Market Share in Value by Type (2020-2025)
 Table 17. Global Plasma Fractionation Sales Market Share in Value by Type (2026-2031)
 Table 18. Global Plasma Fractionation Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 19. Global Plasma Fractionation Sales Value by Application (2020-2025) & (US$ Million)
 Table 20. Global Plasma Fractionation Sales Value by Application (2026-2031) & (US$ Million)
 Table 21. Global Plasma Fractionation Sales Market Share in Value by Application (2020-2025)
 Table 22. Global Plasma Fractionation Sales Market Share in Value by Application (2026-2031)
 Table 23. Global Plasma Fractionation Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 24. Global Plasma Fractionation Sales Value by Region (2020-2025) & (US$ Million)
 Table 25. Global Plasma Fractionation Sales Value by Region (2026-2031) & (US$ Million)
 Table 26. Global Plasma Fractionation Sales Value by Region (2020-2025) & (%)
 Table 27. Global Plasma Fractionation Sales Value by Region (2026-2031) & (%)
 Table 28. Key Countries/Regions Plasma Fractionation Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 29. Key Countries/Regions Plasma Fractionation Sales Value, (2020-2025) & (US$ Million)
 Table 30. Key Countries/Regions Plasma Fractionation Sales Value, (2026-2031) & (US$ Million)
 Table 31. Takeda Basic Information List
 Table 32. Takeda Description and Business Overview
 Table 33. Takeda Plasma Fractionation Products, Services and Solutions
 Table 34. Revenue (US$ Million) in Plasma Fractionation Business of Takeda (2020-2025)
 Table 35. Takeda Recent Developments
 Table 36. CSL Basic Information List
 Table 37. CSL Description and Business Overview
 Table 38. CSL Plasma Fractionation Products, Services and Solutions
 Table 39. Revenue (US$ Million) in Plasma Fractionation Business of CSL (2020-2025)
 Table 40. CSL Recent Developments
 Table 41. Grifols Basic Information List
 Table 42. Grifols Description and Business Overview
 Table 43. Grifols Plasma Fractionation Products, Services and Solutions
 Table 44. Revenue (US$ Million) in Plasma Fractionation Business of Grifols (2020-2025)
 Table 45. Grifols Recent Developments
 Table 46. Octapharma Basic Information List
 Table 47. Octapharma Description and Business Overview
 Table 48. Octapharma Plasma Fractionation Products, Services and Solutions
 Table 49. Revenue (US$ Million) in Plasma Fractionation Business of Octapharma (2020-2025)
 Table 50. Octapharma Recent Developments
 Table 51. Kedrion Basic Information List
 Table 52. Kedrion Description and Business Overview
 Table 53. Kedrion Plasma Fractionation Products, Services and Solutions
 Table 54. Revenue (US$ Million) in Plasma Fractionation Business of Kedrion (2020-2025)
 Table 55. Kedrion Recent Developments
 Table 56. LFB Group Basic Information List
 Table 57. LFB Group Description and Business Overview
 Table 58. LFB Group Plasma Fractionation Products, Services and Solutions
 Table 59. Revenue (US$ Million) in Plasma Fractionation Business of LFB Group (2020-2025)
 Table 60. LFB Group Recent Developments
 Table 61. Biotest Basic Information List
 Table 62. Biotest Description and Business Overview
 Table 63. Biotest Plasma Fractionation Products, Services and Solutions
 Table 64. Revenue (US$ Million) in Plasma Fractionation Business of Biotest (2020-2025)
 Table 65. Biotest Recent Developments
 Table 66. BPL Basic Information List
 Table 67. BPL Description and Business Overview
 Table 68. BPL Plasma Fractionation Products, Services and Solutions
 Table 69. Revenue (US$ Million) in Plasma Fractionation Business of BPL (2020-2025)
 Table 70. BPL Recent Developments
 Table 71. RAAS Basic Information List
 Table 72. RAAS Description and Business Overview
 Table 73. RAAS Plasma Fractionation Products, Services and Solutions
 Table 74. Revenue (US$ Million) in Plasma Fractionation Business of RAAS (2020-2025)
 Table 75. RAAS Recent Developments
 Table 76. CBPO Basic Information List
 Table 77. CBPO Description and Business Overview
 Table 78. CBPO Plasma Fractionation Products, Services and Solutions
 Table 79. Revenue (US$ Million) in Plasma Fractionation Business of CBPO (2020-2025)
 Table 80. CBPO Recent Developments
 Table 81. Hualan Bio Basic Information List
 Table 82. Hualan Bio Description and Business Overview
 Table 83. Hualan Bio Plasma Fractionation Products, Services and Solutions
 Table 84. Revenue (US$ Million) in Plasma Fractionation Business of Hualan Bio (2020-2025)
 Table 85. Hualan Bio Recent Developments
 Table 86. Tiantan Bio Basic Information List
 Table 87. Tiantan Bio Description and Business Overview
 Table 88. Tiantan Bio Plasma Fractionation Products, Services and Solutions
 Table 89. Revenue (US$ Million) in Plasma Fractionation Business of Tiantan Bio (2020-2025)
 Table 90. Tiantan Bio Recent Developments
 Table 91. Shuanglin Bio Basic Information List
 Table 92. Shuanglin Bio Description and Business Overview
 Table 93. Shuanglin Bio Plasma Fractionation Products, Services and Solutions
 Table 94. Revenue (US$ Million) in Plasma Fractionation Business of Shuanglin Bio (2020-2025)
 Table 95. Shuanglin Bio Recent Developments
 Table 96. Boya Bio Basic Information List
 Table 97. Boya Bio Description and Business Overview
 Table 98. Boya Bio Plasma Fractionation Products, Services and Solutions
 Table 99. Revenue (US$ Million) in Plasma Fractionation Business of Boya Bio (2020-2025)
 Table 100. Boya Bio Recent Developments
 Table 101. Yuanda Shuyang Basic Information List
 Table 102. Yuanda Shuyang Description and Business Overview
 Table 103. Yuanda Shuyang Plasma Fractionation Products, Services and Solutions
 Table 104. Revenue (US$ Million) in Plasma Fractionation Business of Yuanda Shuyang (2020-2025)
 Table 105. Yuanda Shuyang Recent Developments
 Table 106. Weiguang Bio Basic Information List
 Table 107. Weiguang Bio Description and Business Overview
 Table 108. Weiguang Bio Plasma Fractionation Products, Services and Solutions
 Table 109. Revenue (US$ Million) in Plasma Fractionation Business of Weiguang Bio (2020-2025)
 Table 110. Weiguang Bio Recent Developments
 Table 111. Nanyue Bio Basic Information List
 Table 112. Nanyue Bio Description and Business Overview
 Table 113. Nanyue Bio Plasma Fractionation Products, Services and Solutions
 Table 114. Revenue (US$ Million) in Plasma Fractionation Business of Nanyue Bio (2020-2025)
 Table 115. Nanyue Bio Recent Developments
 Table 116. KM Biologics Basic Information List
 Table 117. KM Biologics Description and Business Overview
 Table 118. KM Biologics Plasma Fractionation Products, Services and Solutions
 Table 119. Revenue (US$ Million) in Plasma Fractionation Business of KM Biologics (2020-2025)
 Table 120. KM Biologics Recent Developments
 Table 121. Key Raw Materials Lists
 Table 122. Raw Materials Key Suppliers Lists
 Table 123. Plasma Fractionation Downstream Customers
 Table 124. Plasma Fractionation Distributors List
 Table 125. Research Programs/Design for This Report
 Table 126. Key Data Information from Secondary Sources
 Table 127. Key Data Information from Primary Sources
 Table 128. Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Plasma Fractionation Product Picture
 Figure 2. Global Plasma Fractionation Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Plasma Fractionation Sales Value (2020-2031) & (US$ Million)
 Figure 4. Plasma Fractionation Report Years Considered
 Figure 5. Global Plasma Fractionation Players Revenue Ranking (2024) & (US$ Million)
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Plasma Fractionation Revenue in 2024
 Figure 7. Plasma Fractionation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 8. Albumin Picture
 Figure 9. Immune Globulin Picture
 Figure 10. Coagulation Factor Picture
 Figure 11. Others Picture
 Figure 12. Global Plasma Fractionation Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 13. Global Plasma Fractionation Sales Value Market Share by Type, 2024 & 2031
 Figure 14. Product Picture of Hospital
 Figure 15. Product Picture of Retail Pharmacy
 Figure 16. Product Picture of Other
 Figure 17. Global Plasma Fractionation Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 18. Global Plasma Fractionation Sales Value Market Share by Application, 2024 & 2031
 Figure 19. North America Plasma Fractionation Sales Value (2020-2031) & (US$ Million)
 Figure 20. North America Plasma Fractionation Sales Value by Country (%), 2024 VS 2031
 Figure 21. Europe Plasma Fractionation Sales Value, (2020-2031) & (US$ Million)
 Figure 22. Europe Plasma Fractionation Sales Value by Country (%), 2024 VS 2031
 Figure 23. Asia Pacific Plasma Fractionation Sales Value, (2020-2031) & (US$ Million)
 Figure 24. Asia Pacific Plasma Fractionation Sales Value by Region (%), 2024 VS 2031
 Figure 25. South America Plasma Fractionation Sales Value, (2020-2031) & (US$ Million)
 Figure 26. South America Plasma Fractionation Sales Value by Country (%), 2024 VS 2031
 Figure 27. Middle East & Africa Plasma Fractionation Sales Value, (2020-2031) & (US$ Million)
 Figure 28. Middle East & Africa Plasma Fractionation Sales Value by Country (%), 2024 VS 2031
 Figure 29. Key Countries/Regions Plasma Fractionation Sales Value (%), (2020-2031)
 Figure 30. United States Plasma Fractionation Sales Value, (2020-2031) & (US$ Million)
 Figure 31. United States Plasma Fractionation Sales Value by Type (%), 2024 VS 2031
 Figure 32. United States Plasma Fractionation Sales Value by Application (%), 2024 VS 2031
 Figure 33. Europe Plasma Fractionation Sales Value, (2020-2031) & (US$ Million)
 Figure 34. Europe Plasma Fractionation Sales Value by Type (%), 2024 VS 2031
 Figure 35. Europe Plasma Fractionation Sales Value by Application (%), 2024 VS 2031
 Figure 36. China Plasma Fractionation Sales Value, (2020-2031) & (US$ Million)
 Figure 37. China Plasma Fractionation Sales Value by Type (%), 2024 VS 2031
 Figure 38. China Plasma Fractionation Sales Value by Application (%), 2024 VS 2031
 Figure 39. Japan Plasma Fractionation Sales Value, (2020-2031) & (US$ Million)
 Figure 40. Japan Plasma Fractionation Sales Value by Type (%), 2024 VS 2031
 Figure 41. Japan Plasma Fractionation Sales Value by Application (%), 2024 VS 2031
 Figure 42. South Korea Plasma Fractionation Sales Value, (2020-2031) & (US$ Million)
 Figure 43. South Korea Plasma Fractionation Sales Value by Type (%), 2024 VS 2031
 Figure 44. South Korea Plasma Fractionation Sales Value by Application (%), 2024 VS 2031
 Figure 45. Southeast Asia Plasma Fractionation Sales Value, (2020-2031) & (US$ Million)
 Figure 46. Southeast Asia Plasma Fractionation Sales Value by Type (%), 2024 VS 2031
 Figure 47. Southeast Asia Plasma Fractionation Sales Value by Application (%), 2024 VS 2031
 Figure 48. India Plasma Fractionation Sales Value, (2020-2031) & (US$ Million)
 Figure 49. India Plasma Fractionation Sales Value by Type (%), 2024 VS 2031
 Figure 50. India Plasma Fractionation Sales Value by Application (%), 2024 VS 2031
 Figure 51. Plasma Fractionation Industrial Chain
 Figure 52. Plasma Fractionation Manufacturing Cost Structure
 Figure 53. Channels of Distribution (Direct Sales, and Distribution)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS